Centre de coordination de l'évaluation Clinique et de la qualité en Aquitaine (CCECQA), Hôpital Xavier Arnozan, Avenue du Haut Lévêque, 33600, Pessac, France.
BMJ Qual Saf. 2012 Jun;21(6):457-65. doi: 10.1136/bmjqs-2011-000191. Epub 2012 Mar 6.
Patient safety practices, targeting organisational changes for improving patient safety, are implemented worldwide but their costs are rarely evaluated. This paper provides a review of the methods used in economic evaluation of such practices. International medical and economics databases were searched for peer-reviewed publications on economic evaluations of patient safety between 2000 and 2010 in English and French. This was complemented by a manual search of the reference lists of relevant papers. Grey literature was excluded. Studies were described using a standardised template and assessed independently by two researchers according to six quality criteria. 33 articles were reviewed that were representative of different patient safety domains, data types and evaluation methods. 18 estimated the economic burden of adverse events, 3 measured the costs of patient safety practices and 12 provided complete economic evaluations. Healthcare-associated infections were the most common subject of evaluation, followed by medication-related errors and all types of adverse events. Of these, 10 were selected that had adequately fulfilled one or several key quality criteria for illustration. This review shows that full cost-benefit/utility evaluations are rarely completed as they are resource intensive and often require unavailable data; some overcome these difficulties by performing stochastic modelling and by using secondary sources. Low methodological transparency can be a problem for building evidence from available economic evaluations. Investing in the economic design and reporting of studies with more emphasis on defining study perspectives, data collection and methodological choices could be helpful for strengthening our knowledge base on practices for improving patient safety.
患者安全实践旨在针对组织变革以提高患者安全,目前已在全球范围内实施,但这些实践的成本很少得到评估。本文综述了 2000 年至 2010 年间在英文和法文的国际医学和经济学数据库中,针对患者安全实践的经济评估所采用的方法。此外,还对相关文献的参考文献进行了手工检索。排除灰色文献。使用标准化模板对研究进行描述,并由两名研究人员根据 6 项质量标准进行独立评估。共综述了 33 篇文章,这些文章代表了不同的患者安全领域、数据类型和评估方法。其中 18 篇评估了不良事件的经济负担,3 篇测量了患者安全实践的成本,12 篇提供了完整的经济评估。医院感染是最常见的评估对象,其次是药物相关错误和所有类型的不良事件。其中有 10 篇被选中,这些研究在说明一个或多个关键质量标准方面做得足够好。本文综述表明,很少有完整的成本效益/效用评估,因为它们需要大量资源,并且通常需要无法获得的数据;有些通过进行随机建模和使用二手资料来克服这些困难。低方法透明度可能是从现有经济评估中构建证据的一个问题。对研究的经济设计和报告进行更多投资,更注重定义研究视角、数据收集和方法选择,可能有助于加强我们对提高患者安全实践的知识基础。